Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
21.90
-0.03 (-0.14%)
Dec 5, 2025, 4:00 PM EST - Market closed
Evommune Stock Forecast
Stock Price Forecast
The 3 analysts that cover Evommune stock have a consensus rating of "Buy" and an average price target of $39.33, which forecasts a 79.59% increase in the stock price over the next year. The lowest target is $36 and the highest is $42.
Price Target: $39.33 (+79.59%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Evommune stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 |
|---|---|
| Strong Buy | 0 |
| Buy | 5 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Dec 1, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Dec 1, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $36 | Buy | Initiates | $36 | +64.38% | Dec 1, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $42 | Buy | Initiates | $42 | +91.78% | Dec 1, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $40 | Buy | Initiates | $40 | +82.65% | Dec 1, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.